Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious DiseaseRespiratory

PUBLISHER: Grand View Research | PRODUCT CODE: 1362868

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1362868

Respiratory Syncytial Virus Diagnostics Market Size, Share & Trends Analysis Report By Product (DFA, RADT, Molecular Diagnostics, Chromatographic Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Respiratory Syncytial Virus Diagnostics Market Growth & Trends:

The global respiratory syncytial virus diagnostics market is expected to reach USD 1947.3 million by 2030, growing at an estimated CAGR of 9.7% from 2023 to 2030, according to a new study by Grand View Research, Inc.. Increasing neonatal population suffering from respiratory conditions including RSV infections and supportive initiatives for diagnosis of newborns by the healthcare providers are expected to be vital impact rendering drivers for RSV diagnostics market.

According to the statistics provided by the WHO, hospitalization of over 150,000 children (below the age of five) and about 14,000 deaths in geriatric patients occurred in the U.S. in 2014 due to RSV infections. This is anticipated to trigger demand for testing of these conditions over the forecast period.

Furthermore, the global birth rate as of 2014 is 18.7 births per 1,000 individuals, which is predicted to increase the infant population substantially over the next seven years. According to the statistics, it is estimated that about 134.2 million births took place in 2014, which are prone to RSV infections and require diagnosis, thus forming a large market base.

In 2010, Save Babies Through Screening Foundation (SBTS) entered in a partnership with World Solutions Against Infectious Disease (WSAID) as an attempt to promote higher screening of newborns for infectious diseases, metabolic disorders, and hearing disabilities.

Respiratory Syncytial Virus Diagnostics Market Report Highlights:

  • Chromatographic immunoassay technology based products are expected to witness the fastest growth at a CAGR above 10.0% over the next seven years owing to their higher specificity than molecular diagnostic products. The commercially available test kits include Binax Now RSV, QuickLab RSV Test, Remel Xpect, and RSV Respi-Strip.
  • Hospitals are predicted to dominate the RSV diagnostics market followed by home care. Together, they are expected to contribute over 50.0% of the market share in 2022. Increasing demand for home care diagnostic devices by patients is anticipated to drive growth of the segment over the next seven years.
  • North America is anticipated to dominate the market and contribute a revenue share of over 41.5% by 2022. Rising awareness among the population base and favorable initiatives by the government agencies such as the WHO, PAHO, and WSAID to initiate and implement newborn screening are expected to drive growth.
  • Key players of the market include Alere Inc., EMD Millipore, BD and Company, Ortho Clinical Diagnostics, Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific Inc. CLIA waiver and launch of RSV assays by companies like Roche Diagnostics, Becton Dickinson and Company, and Alere Inc. are expected to boost market growth over the forecast period.
Show more
Product Code: 978-1-68038-680-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Respiratory Syncytial Virus (RSV) Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Respiratory Syncytial Virus (RSV) Diagnostic Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Respiratory Syncytial Virus (RSV) Diagnostic Market: Product Estimates & Trend Analysis

  • 4.1. Respiratory Syncytial Virus (RSV) Diagnostic Market: Key Takeaways
  • 4.2. Respiratory Syncytial Virus (RSV) Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Direct Fluorescent Antibody (DFA) Method
    • 4.3.1. Direct fluorescent antibody (DFA) Method estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Rapid Antigen Diagnostic Test (RADT)
    • 4.4.1. Rapid Antigen Diagnostic Test (RADT) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Molecular Diagnostics
    • 4.5.1. Molecular diagnostic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Chromatographic Immunoassay
    • 4.6.1. Chromatographic immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Diagnostic Imaging
    • 4.7.1. Diagnostic imaging Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Gel Microdroplets
    • 4.8.1. Gel microdroplets imaging immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Flow Cytometry
    • 4.9.1. Flow cytometry imaging immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Respiratory Syncytial Virus (RSV) Diagnostic Market: End-use Estimates & Trend Analysis

  • 5.1. Respiratory Syncytial Virus (RSV) Diagnostic Market: Key Takeaways
  • 5.2. Respiratory Syncytial Virus (RSV) Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Laboratory
    • 5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Clinics
    • 5.5.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Homecare
    • 5.6.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Respiratory Syncytial Virus (RSV) Diagnostic Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Respiratory Syncytial Virus (RSV) Diagnostic Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Becton, Dickinson and Company
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Novartis AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Abbott
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Ortho Clinical Diagnostics
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Thermo Fisher Scientific Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Bio-Rad Laboratories, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. F. Hoffmann-La Roche Ltd
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. BIOMERIEUX
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. DiaSorin S.p.A.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Merck KGaA
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Quidel Corporation
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Coris BioConcept
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Quest Diagnostics
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Siemens Healthcare S.A.
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
Show more
Product Code: 978-1-68038-680-6

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 12 UK respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 13 UK respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Germany respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 15 Germany respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 17 France respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific respiratory syncytial virus diagnostic market, by region, (USD Million) 2018 - 2030
  • Table 31 Japan respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 34 China respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 36 India respiratory syncytial virus diagnostic market, by end-use, (USD Million) 2018 - 2030
  • Table 37 Australia respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Respiratory syncytial virus diagnostic: Market outlook
  • Fig. 9 Respiratory syncytial virus diagnostic: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Respiratory syncytial virus diagnostic market driver impact
  • Fig. 15 Respiratory syncytial virus diagnostic market restraint impact
  • Fig. 16 Respiratory syncytial virus diagnostic market strategic initiatives analysis
  • Fig. 17 Respiratory syncytial virus diagnostic market: Product movement analysis
  • Fig. 18 Respiratory syncytial virus diagnostic market: product outlook and key takeaways
  • Fig. 19 Direct fluorescent antibody (DFA) method market estimates and forecasts, 2018 - 2030
  • Fig. 20 Rapid antigen diagnostic test (RADT) market estimates and forecasts, 2018 - 2030
  • Fig. 21 Molecular diagnostic market estimates and forecasts, 2018 - 2030
  • Fig. 22 Chromatographic immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 23 Diagnostic imaging market estimates and forecasts, 2018 - 2030
  • Fig. 24 Gel microdroplets immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 25 Flow cytometry immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030
  • Fig. 27 Respiratory syncytial virus diagnostic market: End-use movement analysis
  • Fig. 28 Respiratory syncytial virus diagnostic market: End-use outlook and key takeaways
  • Fig. 29 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 30 Laboratory market estimates and forecasts, 2018 - 2030
  • Fig. 31 Clinics market estimates and forecasts, 2018 - 2030
  • Fig. 32 Homecare market estimates and forecasts, 2018 - 2030
  • Fig. 33 Global respiratory syncytial virus diagnostic market: Regional movement analysis
  • Fig. 34 Global respiratory syncytial virus diagnostic market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 38 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 41 France market estimates and forecasts, 2018 - 2030
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 45 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 46 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 49 China market estimates and forecasts, 2018 - 2030
  • Fig. 50 India market estimates and forecasts, 2018 - 2030
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 58 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!